Researchers at the Francis Crick Institute, University College London, and Imperial College London have identified a new biological pathway critical in driving inflammatory bowel disease (IBD) and other related conditions such as Crohn's disease and ulcerative colitis.

We welcome our newest network member, Living with IgG4-Related Diseases, a global and private Facebook group with over 2,400 members of which the majority are patients, caregivers, and allies.

Alopecia areata (AA) is an autoimmune disease that mistakenly attacks hair follicles and leads to hair loss. It affects nearly 7 million people in the United States.

In autoimmune diseases, many conditions share similar symptoms as well as similar treatments. Off-label drugs are often used to treat autoimmune diseases for which they were not originally approved.

In one of our previous newsletters, we discussed the psychological and neurological impacts of autoimmune diseases, in that some patients with autoimmune conditions like lupus and rheumatoid arthritis may experience neurological conditions that tend to be overlooked.

Artificial intelligence (AI) has become a major force in healthcare by revolutionizing the practice of medicine and how people are treated.

In honor of Lupus Awareness Month, we wanted to share Emmitt Henderson III's story, whose journey is a testament to the resilience of the human spirit.

May is Lupus Awareness Month! Help raise awareness to support early diagnosis and proper disease management for patients. With advocacy and awareness, more funding can go toward the research of new drugs and treatments to improve patient outcomes.

In a recent discovery, UC San Francisco (UCSF) scientists have found a revolutionary method for identifying early biomarkers for multiple sclerosis (MS).

One of the Autoimmune Registry's goals is to increase awareness of autoimmune diseases to improve existing treatment protocols and disease management strategies. Clinical trials are a crucial part of testing new treatments and participation is important to ensure that new medications are approved for the public.

Although there are various treatment options for autoimmune disease, researchers are always looking to develop the next best treatment. Scientists at Mayo Clinic have developed an innovative immunotherapy approach that could revolutionize autoimmune disease treatment.

Once thought to be a rare disease, Sjogren's is now recognized as one of the most prevalent autoimmune diseases, affecting an estimated 1 to 4 million people in the United States.

Autoimmune diseases are notorious for their lengthy diagnostic process. Patients often suffer for years without a diagnosis or are misdiagnosed, leading to delays in proper treatment.

New research on rheumatoid arthritis (RA) has focused on the early stages of the disease when intervention may help prevent or mitigate the disease.

Lichen Sclerosus (LS) is a chronic inflammatory skin condition that causes patches of skin to look white, thickened, and crinkly around the genital and anal areas. While this condition can occur in both men and women, it is more commonly diagnosed in women.

Although March is Autoimmune Awareness Month, it is also Women's History Month. It is no surprise that these two celebrations coincide, especially since autoimmune diseases stand out as a significant and often overlooked aspect of women's health.

Every day, millions of autoimmune disease patients suffer in silence with what are often "invisible" illnesses. With March set as Autoimmune Disease Awareness Month, this is our time to advocate for our diseases and show the world who we are!

The National Institutes of Health defines a rare disease as one that affects fewer than 200,000 persons in the US. But is every rare disease truly rare?

World Encephalitis Day occurs every February 22nd to raise global awareness for those who have been affected by encephalitis, a condition characterized by inflammation of the brain.

In honor of Black History Month, the Autoimmune Registry is focusing on the intersections between health and identity.